Renin is a pepsin-like aspartyl protease and an important drug target for the treatment of hypertension; despite three decades' research, its pH-dependent structure-function relationship remains poorly understood. Here we employed the continuous constant pH molecular dynamics (CpHMD) simulations to decipher the acid/base roles of renin's catalytic dyad and the conformational dynamics of the flap, which is a common structural feature among aspartyl proteases. The calculated pK a 's suggest that the catalytic Asp38 and Asp226 serve as the general base and acid, respectively, in agreement with experiment and supporting the hypothesis that renin's neutral optimum pH is due to the substrate-induced pK a shifts of the aspartic dyad. The CpHMD data confirmed our previous hypothesis that hydrogen bond formation is the major determinant of the dyad pK a order. Additionally, our simulations showed that renin's flap remains open regardless of pH, although a Tyr-inhibited state is occasionally formed above pH 5. These findings are discussed in comparison to the related aspartyl proteases, including β-secretases 1 and 2, capthepsin D, and plasmepsin II. Our work represents a first step towards a systematic understanding of the pH-dependent structure-dynamics-function relationships of pepsin-like aspartyl proteases that play important roles in biology and human disease states.Renin-angiotensin-aldosterone system (RAAS) is a critical regulator for blood pressure and systemic vascular resistance. 1,2 As a part of the RAAS system, the aspartic protease renin cleaves a protein called angiotensinogen to generate an inactive decapeptide, angiotensin I, which is further cleaved by the angiotensin converting enzyme (ACE) to produce shorter peptides, including the octapeptide angiotensin II which binds and activates the angiotensin II type 1 (AT 1 ) and type 2 (AT 2 ) receptors. The primary effects of AT 1 receptor activation include vasoconstriction and stimulation of aldosterone synthesis and release with subsequent sodium and fluid retention, which tend to elevate blood pressure. 1 Because of its essential role in the function of RAAS and the high specificity for its only known substrate angiotensinogen, renin is an attractive drug target for the treatment of hypertension. Despite